Instituto Nacional de Cancerología - Academic Profile

Publications

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

H. Borghaei , L. Paz-Ares , Leora Horn +25 more

Among patients with advanced nonsquamous NSCLC that had progressed during or after platinum-based chemotherapy, overall survival was longer with nivolumab than with docetaxel. (...

2015 New England Journal of Medicine 9225 citations

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

Edward B. Garon , Tudor‐Eliade Ciuleanu , Óscar Arrieta +23 more

2014 The Lancet 1263 citations

Affiliated Researchers

Óscar Arrieta

Instituto Nacional de Cancerología

Institution Info

Type: government
Country: MX
Publications: 2
Citations: 10,488

External Links

Identifiers

ROR: https://ror.org/04z3afh10